Boston, MANCT05688969Now EnrollingIRB Ready

Osteoporosis, Postmenopausal Clinical Trial in Boston, MA

Access cutting-edge osteoporosis, postmenopausal treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access osteoporosis, postmenopausal specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteoporosis, postmenopausal treatment provided free

Apply for This Boston Location

Check if you qualify for this osteoporosis, postmenopausal clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Osteoporosis, Postmenopausal Study in Boston

The aim of this study is to investigate the effect of romosozumab on bone cells during early and late phases of treatment.

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

All postmenopausal women who are prescribed romosozumab by their treating physicians, meet the FDA-defined indication for romosozumab, and who are not at increased risk for a bone marrow aspirate or bone biopsy will be offered enrollment. The FDA approved indication for romosozumab is: "the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy." Volunteers must be:
Female aged \> 45 years
Postmenopausal by either of the following criteria:
\> 36 since last spontaneous menses
\> 36 months since hysterectomy, plus serum FSH \> 40 units / liter if \< 60 years

Exclusion Criteria

renal disease (stage 4 CKD)
elevated blood PTH (intact PTH \> 77 pg/ml).
serum 25-OH vitamin D \< 20 ng/ml
major psychiatric disease that in the opinion of the investigator would preclude the subject from providing adequate informed consent or completing the protocol procedures.
excessive alcohol use or substance abuse that would preclude the subject from providing adequate informed consent or completing the protocol procedures.
known congenital or acquired bone disease other than osteoporosis.
exposure to oral bisphosphonates within the past 3 months, denosumab in the last 12 months, intravenous bisphosphonates within the past 24 months.
exposure to estrogens, SERMs, or calcitonin, oral or parenteral glucocorticoids for more than 14 days in the past 2 months.
any prior exposure to romosozumab.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT05688969) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteoporosis, Postmenopausal Treatment Options in Boston, MA

If you're searching for osteoporosis, postmenopausal treatment options in Boston, MA, this clinical trial (NCT05688969) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteoporosis, postmenopausal specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteoporosis, postmenopausal clinical trials near you to find additional studies recruiting in your area.

More Osteoporosis Trials in Boston, MA

See all osteoporosis clinical trials recruiting in Boston — not just this study.

Browse Osteoporosis Trials in Boston →

Browse More Trials by Condition

Osteoporosis TrialsMenopause TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA